InvestorsHub Logo
Followers 83
Posts 2557
Boards Moderated 0
Alias Born 06/15/2018

Re: Nestegg McMuffin post# 10

Tuesday, 04/23/2019 10:08:54 PM

Tuesday, April 23, 2019 10:08:54 PM

Post# of 94
Correction: Looks like $VRUS investor Andrew Garnock spent $410K for a wholly owned subsidiary called Mount Tam Delaware, and any of the main company's biotech projects were spun off into another new subsidiary called Mount Tam Therapeutics.


On October 18, 2018, the “Company” and Mount Tam, its wholly-owned subsidiary, entered into a stock purchase agreement (the “SPA”) with ARJ Consulting, LLC, a New York limited liability company (the “Buyer”), pursuant to which the Company sold 100% of the capital stock in and of Mount Tam to the Buyer (the “Sale Transaction”). Prior to the Sale Transaction, the Company caused Mount Tam to transfer certain assets, including the Buck Institute License Agreement, that Mount Tam was holding to another wholly-owned subsidiary of the Company, Mount Tam Therapeutics, Inc., a Delaware corporation. At the time of the Sale Transaction Mount Tam possessed certain Net Operating Losses and tax credits. Pursuant to the terms of the SPA, the Buyer purchased Mount Tam for a purchase price of $410,000.